|
2024
|
Invention
|
Multi-parameter metabolic vulnerability index evaluations.
Disclosed are methods and systems to ... |
|
2023
|
Invention
|
Metabolic vulnerability analyzed by nmr |
|
|
Invention
|
Metabolic vulnerability analyzed by nmr. Disclosed are methods and systems for evaluating various... |
|
2021
|
Invention
|
Multiple-marker risk parameters predictive of conversion to diabetes. Methods, systems and circui... |
|
2020
|
Invention
|
Nmr quantification of tmao. A defined peak region residing between about 3.2 and 3.4 ppm of a pro... |
|
2019
|
Invention
|
Methods to predict liver disease mortality using lipoprotein lp-z. Described herein are methods f... |
|
|
Invention
|
Methods, systems and computer programs for assessing chd risk using adjusted hdl particle number ... |
|
2018
|
Invention
|
Methods and systems to detect and quantify the amount of lp-x and other abnormal lipoproteins in ... |
|
|
Invention
|
Multi-parameter metabolic vulnerability index evaluations. Disclosed are methods and system... |
|
|
Invention
|
Multi-parameter metabolic vulnerability index evaluations. Disclosed are methods and systems to d... |
|
2017
|
Invention
|
Methods and systems for predicting colorectal cancer incidence and mortality. Disclosed are metho... |
|
2016
|
Invention
|
Methods, systems and computer programs for assessing chd risk using adjusted hdl article number m... |
|
2015
|
Invention
|
Cardiovascular risk evaluations using a risk parameter that includes an hdl and inflammatory biom... |
|
2013
|
Invention
|
Nmr quantification of branched chain amino acids. The present invention relates generally to the ... |
|
|
Invention
|
Multi-parameter diabetes risk evaluations. Methods, systems and circuits evaluate a subject's ris... |
|
|
Invention
|
Nmr measurements of glyca. Biomarkers and/or risk assessments identify patients having an i... |
|
|
Invention
|
Nmr measurements of glyca. Biomarkers and/or risk assessments identify patients having an increas... |
|
2012
|
Invention
|
Quantitative nmr clinical analyzers with automatic nmr temperature sensitivity compensation that ... |
|
2009
|
Invention
|
Lipoprotein insulin resistance indexes and related methods, systems and computer programs for gen... |
|
2007
|
Invention
|
Methods, systems and computer programs for assessing chd risk using weighted hdl particle number ... |
|
|
Invention
|
Nmr measurement of clinically relevant ionized biosample constituents such as ionized calcium and... |
|
2005
|
Invention
|
Nmr clinical analyzers and related methods, systems, modules and computer program products for cl... |
|
2004
|
Invention
|
Methods, systems and computer programs for assessing chd risk using mathematical models that cons... |
|
2003
|
Invention
|
Methods, systems and computer programs for deconvolving the spectral contribution of chemical con... |
|
2002
|
Invention
|
Method of determining presence and concentration of lipoprotein x in blood plasma and serum. A me... |
|
2000
|
Invention
|
Nmr-method for determining the risk of developing type 2 diabetes. Methods for assessing th... |
